• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺素E1、血管痉挛性疾病与热成像

Prostaglandin E1 vasospastic disease and thermography.

作者信息

Kyle V, Parr G, Salisbury R, Thomas P P, Hazleman B

出版信息

Ann Rheum Dis. 1985 Feb;44(2):73-8. doi: 10.1136/ard.44.2.73.

DOI:10.1136/ard.44.2.73
PMID:3977414
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1001576/
Abstract

This is the first study to show a quantitative thermographic difference between patients with Raynaud's syndrome and normal controls after cold stress testing. An improved thermographic response to cold stress testing after treatment of Raynaud's syndrome with PGE1 has also been shown for the first time. Discriminant analysis of the change in temperature of a finger after cold stress, and the mean thermal gradient along the finger during rewarming, clearly separated patients from controls. After treatment with PGE1 the patients' discriminant values moved into the normal range. Symptomatic improvement after PGE1 correlated well with thermographic improvement, and both persisted for up to 12 weeks.

摘要

这是第一项显示在冷应激测试后,雷诺综合征患者与正常对照者之间存在定量热成像差异的研究。首次还表明,用PGE1治疗雷诺综合征后,对冷应激测试的热成像反应有所改善。对冷应激后手指温度变化以及复温过程中沿手指的平均热梯度进行判别分析,能清晰地将患者与对照者区分开来。用PGE1治疗后,患者的判别值进入正常范围。PGE1治疗后的症状改善与热成像改善密切相关,且两者均持续长达12周。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ae/1001576/f6277ba0df63/annrheumd00257-0004-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ae/1001576/64926cdb96f6/annrheumd00257-0001-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ae/1001576/a1ec355db18f/annrheumd00257-0002-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ae/1001576/2bc398400410/annrheumd00257-0002-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ae/1001576/aa4130ffa4fa/annrheumd00257-0004-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ae/1001576/f6277ba0df63/annrheumd00257-0004-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ae/1001576/64926cdb96f6/annrheumd00257-0001-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ae/1001576/a1ec355db18f/annrheumd00257-0002-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ae/1001576/2bc398400410/annrheumd00257-0002-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ae/1001576/aa4130ffa4fa/annrheumd00257-0004-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47ae/1001576/f6277ba0df63/annrheumd00257-0004-b.jpg

相似文献

1
Prostaglandin E1 vasospastic disease and thermography.前列腺素E1、血管痉挛性疾病与热成像
Ann Rheum Dis. 1985 Feb;44(2):73-8. doi: 10.1136/ard.44.2.73.
2
Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis.前列腺素E1输注治疗进行性系统性硬化症的血管功能不全
Ann Rheum Dis. 1981 Aug;40(4):350-4. doi: 10.1136/ard.40.4.350.
3
Pyroelectric vidicon thermography and cold challenge quantify the severity of Raynaud's phenomenon.热释电视像管热成像术和冷刺激可量化雷诺现象的严重程度。
Br J Rheumatol. 1991 Jun;30(3):190-5. doi: 10.1093/rheumatology/30.3.190.
4
Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.使用选择性5-羟色胺再摄取抑制剂氟西汀治疗雷诺现象。
Rheumatology (Oxford). 2001 Sep;40(9):1038-43. doi: 10.1093/rheumatology/40.9.1038.
5
Use of prostaglandin E1 (lipo-PGE1) to treat Raynaud's phenomenon associated with connective tissue disease: thermographic and subjective assessment.使用前列腺素E1(脂微球载体前列腺素E1)治疗与结缔组织病相关的雷诺现象:热成像和主观评估。
J Pharm Pharmacol. 1992 May;44(5):442-4. doi: 10.1111/j.2042-7158.1992.tb03641.x.
6
A multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud's syndrome.一项关于前列腺素E1治疗雷诺氏综合征的多诊所、安慰剂对照、双盲研究。
Ann Rheum Dis. 1985 Nov;44(11):754-60. doi: 10.1136/ard.44.11.754.
7
Haemorrheological effects of prostaglandin E1 infusion in Raynaud's syndrome.前列腺素E1输注对雷诺综合征的血液流变学影响。
J Clin Pathol. 1984 Aug;37(8):870-3. doi: 10.1136/jcp.37.8.870.
8
Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis.原发性雷诺现象及与系统性硬化症相关的雷诺现象中冷刺激反应的测量。
Ann Rheum Dis. 1992 Nov;51(11):1193-6. doi: 10.1136/ard.51.11.1193.
9
Thermographic parameters in the diagnosis of secondary Raynaud's phenomenon.热成像参数在继发性雷诺现象诊断中的应用
Arch Phys Med Rehabil. 2000 Apr;81(4):495-9. doi: 10.1053/mr.2000.4870.
10
Prostaglandin E1 in severe Raynaud's phenomenon.
Surgery. 1982 Dec;92(6):953-65.

引用本文的文献

1
Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis.多国定性研究探索系统性硬化症患者雷诺现象的体验。
Arthritis Care Res (Hoboken). 2018 Sep;70(9):1373-1384. doi: 10.1002/acr.23475. Epub 2018 Aug 16.
2
Quantifying digital vascular disease in patients with primary Raynaud's phenomenon and systemic sclerosis.量化原发性雷诺现象和系统性硬化症患者的数字血管疾病。
Ann Rheum Dis. 1998 Feb;57(2):70-8. doi: 10.1136/ard.57.2.70.
3
Managing Raynaud's phenomenon.治疗雷诺现象。

本文引用的文献

1
Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis.前列腺素E1输注治疗进行性系统性硬化症的血管功能不全
Ann Rheum Dis. 1981 Aug;40(4):350-4. doi: 10.1136/ard.40.4.350.
2
Prostaglandin E1 therapy for digital ulcers in scleroderma.前列腺素E1治疗硬皮病指端溃疡
Can Med Assoc J. 1982 Jan 1;126(1):42-5.
3
Raynaud syndrome.雷诺综合征
Br Med J (Clin Res Ed). 1986 Jul 12;293(6539):88-9. doi: 10.1136/bmj.293.6539.88.
4
Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis.输注伊洛前列素(一种前列环素类似物)用于治疗系统性硬化症中的雷诺现象。
Ann Rheum Dis. 1988 Jan;47(1):43-7. doi: 10.1136/ard.47.1.43.
5
Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis.系统性硬化症患者输注伊洛前列素后指端血流持续增加。
Postgrad Med J. 1987 Aug;63(742):617-20. doi: 10.1136/pgmj.63.742.617.
6
Prolonged effect of CGRP in Raynaud's patients: a double-blind randomised comparison with prostacyclin.降钙素基因相关肽对雷诺氏病患者的长期疗效:与前列环素的双盲随机对照研究
Br J Clin Pharmacol. 1991 Aug;32(2):209-13. doi: 10.1111/j.1365-2125.1991.tb03883.x.
7
A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases.两剂量静脉注射伊洛前列素治疗结缔组织病继发雷诺现象的双盲、随机、多中心比较
Ann Rheum Dis. 1991 Nov;50(11):800-4. doi: 10.1136/ard.50.11.800.
Semin Arthritis Rheum. 1981 May;10(4):282-308. doi: 10.1016/0049-0172(81)90006-8.
4
The effect of cold on blood flow in the hand of patients with Raynaud's phenomenon.寒冷对雷诺现象患者手部血流的影响。
Clin Sci. 1973 Mar;44(3):279-89. doi: 10.1042/cs0440279.
5
Raynaud's phenomenon. Photoelectric plethysmography of the fingers of persons with and without Raynaud's phenomenon during cooling and warming up.雷诺现象。有和没有雷诺现象的人在手指冷却和升温过程中的光电体积描记法。
Acta Med Scand. 1977;201(6):519-23.
6
Fate of prostaglandins E(1) and A(1) in the human pulmonary circulation.前列腺素E(1)和A(1)在人体肺循环中的命运。
Surgery. 1977 Jun;81(6):716-22.
7
Assessment of cold sensitivity in Raynaud's phenomenon associated with scleroderma.
Microvasc Res. 1978 Mar;15(2):251-6. doi: 10.1016/0026-2862(78)90024-9.